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**Abstract**

Major Depressive Disorder (MDD) is an incapacitating condition associated with significant personal, social and economic impairment. Nearly 30% of patients present drug refractoriness, reinforcing the need to develop novel therapeutic strategies for MDD. Transcranial direct current stimulation (tDCS) might be an alternative for these patients considering its tolerability, portability and ease of use. The tDCS technique alters neuronal resting membrane potentials to facilitate (anodal) and inhibit (cathodal) neuronal firing rates. The antidepressant effects of tDCS are based on neuroimaging studies, which have shown that, in depression, the left dorsolateral prefrontal cortex (DLPFC) is hypoactive and the right DLPFC is hyperactive. To achieve antidepressant effects, anodal tDCS is delivered over the left region for depolarization and cathodal tDCS is delivered over the right DLPFC for hyperpolarization. In this presentation, we review putative tDCS antidepressant mechanisms as well as clinical evidence based on recent controlled studies and meta-analyses evaluating tDCS efficacy and predictors of response for MDD. Present evidence indicates that tDCS may be an effective treatment strategy for MDD. There are no studies specifically examining the efficacy of tDCS in bipolar depression and mania, which are urgently needed in order to address tDCS effectiveness for bipolar disorder. In addition, there are reports of hypomania/mania after or during tDCS treatment; this risk should be prospectively investigated in further studies.
